WorldNews Posted April 12, 2016 Share Posted April 12, 2016 TRENTON, N.J. (AP) — The U.S. Food and Drug Administration on Monday approved a new type of drug that targets a subset of leukemia patients with a genetic abnormality that makes the cancer harder to treat. Continue reading... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.